市场调查报告书
商品编码
1467783
2024-2032 年按产品类型、便携性、最终用户、应用和地区分類的雾化器市场报告Nebulizers Market Report by Product Type, Portability, End-User, Application, and Region 2024-2032 |
2023年全球雾化器市场规模达14IMARC Group美元。
雾化器是患有呼吸系统疾病的患者用来将药物直接注射到肺部的设备。这些装置通常由马达、吸嘴、杯子和管道组成,利用氧气、压缩空气或超音波功率将液体药物分解成气雾剂,将液体药物变成细雾。医生开处方给使用吸入器时无法深呼吸的人。雾化器主要用于缓解极端呼吸状况,例如慢性阻塞性肺病(COPD)、气喘、囊性纤维化等。
慢性呼吸道疾病盛行率上升是推动市场成长的主要因素。繁忙的日程、久坐的生活方式和缺乏体力活动导致全球肥胖率上升。这与烟草和酒精消费量的增加相结合,极大地导致了呼吸系统疾病的发生率增加,从而促进了雾化器的销售。除此之外,由于私家车的使用增加和工业扩张而导致的污染程度上升是影响全球产品需求的另一个关键因素。此外,老年人口的成长导致对家庭医疗保健设备的需求增加,从而推动了对便携式设备的需求。此外,一些组织正在采取倡议,提高人们对呼吸系统疾病可用治疗方案的认识。例如,慢性阻塞性肺病全球倡议 (GOLD) 正在积极向公众宣传慢性阻塞性肺病带来的风险及其治疗方法。
The global nebulizers market size reached US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.5% during 2024-2032.
Nebulizers are devices that are used by patients suffering from respiratory diseases to administer the medication directly into the lungs. Usually made up of a motor, mouthpiece, cup and tubing, these devices turn liquid medicine into a fine mist by using oxygen, compressed air or ultrasonic power for breaking up the liquid drug into aerosols. They are prescribed by doctors to people who are unable to breathe deeply while using an inhaler. Nebulizers are primarily utilized for providing relief from extreme breathing conditions such as chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, etc.
Rising prevalence of chronic respiratory diseases is a major factor boosting the growth of the market. Busy schedules, sedentary lifestyles and a lack of physical activities have led to an increase in prevalence of obesity across the globe. This, in confluence with escalating consumption of tobacco and alcohol, is significantly contributing to the increasing occurrence of respiratory disorders, thereby bolstering the sales of nebulizers. Apart from this, rising pollution levels on account of increasing adoption of private vehicles and expansion of industries is another key factor that is contributing to the product's demand globally. Moreover, the growing geriatric population has led to an increase in the demand for home healthcare devices, which is driving the demand for portable variants. Furthermore, several organizations are taking initiatives to spread awareness about the available treatment options for respiratory diseases. For instance, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) is actively educating the public about the risks posed by COPD and the treatment of the same.
IMARC Group provides an analysis of the key trends in each sub-segment of the global nebulizers market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on product type, portability, end-user and application.
Pneumatic Nebulizers
Ultrasonic Nebulizers
Mesh Nebulizers
Others
Portable Nebulizers
Standalone Nebulizers
Hospitals and Clinics
Long Term Healthcare Centers
Homecare Settings
Outpatient Settings
COPD
Cystic Fibrosis
Asthma
Others
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
The report has also analysed the competitive landscape of the market with some of the key players being Briggs Medical Service Company, Ca-Mi SRL, Besco Medical, Flyp Nebulizers, DeVilbiss Healthcare International, Omron Corporation, Becton, Dickinson and Company, Koninklijke Philips N.V., Feellife Health Inc., Invacare Corporation, Pari Medical Ltd., Philips Respironics, Inc., Agilent Technologies, Inc., Medline Industries, Inc. and Graham Field (GF) Health Products, Inc.